Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18542,897,1.19 [1.07-1.33],0.0015936394231444
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17810,292,1.38 [1.15-1.65],0.0004065555624328
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,21010,174,1.35 [1.08-1.68],0.0095133834605447
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13037,1068,1.37 [1.24-1.52],2.9580405013117476e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,20963,127,1.34 [1.03-1.74],0.0268292277248948
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,18573,95,1.58 [1.19-2.10],0.0016067028448225
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22395,126,1.34 [1.03-1.73],0.0295657357775698
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22381,83,1.09 [0.77-1.54],0.6204735151316987
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18094,70,1.30 [0.90-1.88],0.164672003552585
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,21272,131,1.40 [1.09-1.81],0.0094711743758185
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,21227,86,1.66 [1.25-2.21],0.0005263231079846
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,22498,66,1.25 [0.86-1.84],0.2458236571217099
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,22527,65,0.98 [0.65-1.47],0.912216073777905
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",22524,62,1.05 [0.69-1.58],0.8311372154242643
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Mycoses,22042,60,1.19 [0.80-1.78],0.3921950023825895
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",20949,432,1.13 [0.96-1.31],0.135655464967366
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,20653,136,1.41 [1.10-1.82],0.0070616697849162
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,20829,312,1.03 [0.85-1.23],0.7920551774622689
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",16218,100,0.75 [0.52-1.06],0.1055869156648066
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16182,64,0.67 [0.42-1.08],0.1002580142538651
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16504,386,1.17 [0.99-1.39],0.0598707275869735
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16516,398,1.17 [0.99-1.38],0.0641338883211652
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",9260,374,1.24 [1.04-1.47],0.0158709854163133
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7437,205,1.23 [0.99-1.53],0.0654462834814794
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16172,54,1.94 [1.39-2.71],0.0001034693030127
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19240,751,1.25 [1.11-1.40],0.0002064258893384
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",21035,458,1.09 [0.94-1.26],0.2768785257133361
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22005,152,1.26 [0.98-1.61],0.0677136457104802
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22581,148,1.11 [0.85-1.44],0.442992395138821
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Rectum,22269,82,1.12 [0.79-1.60],0.5094115979045101
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,22586,92,0.98 [0.69-1.39],0.9068969367141524
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Stomach,22639,67,1.11 [0.74-1.67],0.6002225222881337
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm,22404,289,0.96 [0.79-1.17],0.6874507950677353
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,22620,99,0.86 [0.61-1.22],0.3977736913418263
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,22624,84,0.95 [0.65-1.37],0.771698640712913
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",22542,58,1.51 [1.03-2.20],0.0349866615654466
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma, any site",22544,57,1.54 [1.05-2.25],0.026227309501391
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi,22482,142,0.93 [0.70-1.24],0.6266759326985383
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,22616,59,0.81 [0.51-1.28],0.3589982459851607
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Other benign neoplasms of skin,22505,175,1.08 [0.84-1.38],0.560760148823821
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of breast,11803,44,0.88 [0.53-1.48],0.6379080730004703
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Leiomyoma of uterus,11666,300,1.09 [0.89-1.32],0.4183509984087428
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,21091,188,1.20 [0.96-1.51],0.1126429330218949
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,20570,348,1.26 [1.07-1.49],0.0054329736735865
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,20570,348,1.26 [1.07-1.49],0.0054329736735865
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18059,554,1.28 [1.12-1.47],0.0002794397068338
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22044,57,1.61 [1.11-2.35],0.0123756528248842
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22304,62,1.00 [0.66-1.51],0.9838386532417508
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,16358,1626,1.18 [1.08-1.28],0.0001351637238417
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,20941,629,1.19 [1.04-1.35],0.0085511181667134
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,19902,156,1.19 [0.93-1.52],0.176158896040227
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21073,163,1.88 [1.54-2.28],2.3301806445858966e-10
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,19889,143,1.18 [0.91-1.53],0.2075563758919367
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,20506,760,0.98 [0.87-1.11],0.7432147931613653
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,20481,735,0.96 [0.85-1.09],0.5378089341889902
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,20797,183,1.10 [0.85-1.42],0.4820268478909462
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",20797,183,1.10 [0.85-1.42],0.4820268478909462
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16176,1444,1.19 [1.08-1.30],0.0001992303307276
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",14922,190,1.18 [0.94-1.49],0.1538350934890162
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,16065,1333,1.20 [1.09-1.31],0.0001242626978191
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,14789,57,1.31 [0.88-1.95],0.1835810505373206
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14823,91,1.15 [0.83-1.60],0.405595586682317
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Any mental disorder,18525,527,1.33 [1.17-1.52],2.098498166053664e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18156,158,1.29 [1.02-1.62],0.0342860090587316
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22287,111,0.98 [0.73-1.31],0.8820549419177787
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22344,83,0.98 [0.70-1.37],0.9117496041043188
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21123,33,1.50 [0.95-2.38],0.0829580109233088
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",22566,33,1.44 [0.90-2.32],0.1299026619542734
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",18031,33,1.52 [0.96-2.42],0.0773497608890074
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Alcohol dependence,21131,41,1.33 [0.86-2.07],0.1974120053793834
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Smoking dependency,21053,49,1.76 [1.24-2.50],0.0016463577338329
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18033,35,2.05 [1.38-3.05],0.0003611146238636
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",18254,256,1.43 [1.19-1.72],0.0001085245155571
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Depression,21216,227,1.40 [1.15-1.70],0.0006760956735966
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Depression or dysthymia,17899,195,1.43 [1.16-1.76],0.000823510340687
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",18101,103,1.09 [0.79-1.49],0.6072419785432435
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Other anxiety disorders,21268,60,1.05 [0.69-1.59],0.8317600839274748
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Neurological diseases,18388,1458,1.12 [1.02-1.22],0.0133610422652601
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16085,100,0.95 [0.68-1.34],0.7827371525416154
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,22550,77,1.02 [0.70-1.50],0.8991404623428237
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,21341,458,1.14 [0.98-1.32],0.0858953059012728
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Epilepsy,21010,127,1.04 [0.78-1.39],0.776517918372349
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Migraine,20938,55,1.32 [0.88-1.98],0.175583728840763
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",22414,50,1.35 [0.89-2.05],0.16198286762721
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,21488,116,1.17 [0.88-1.56],0.2854783746536784
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other sleep disorders,21042,159,1.22 [0.96-1.56],0.1067645139116568
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Sleep apnoea,22114,118,1.15 [0.86-1.53],0.3552471270482159
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",21470,703,1.14 [1.01-1.29],0.0379243923971002
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",20868,101,1.11 [0.81-1.52],0.5067961164754713
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21195,428,1.04 [0.89-1.23],0.6166577551110366
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22260,77,1.20 [0.85-1.70],0.2979945818431297
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Hemiplegia,22241,58,1.22 [0.82-1.80],0.321808322392662
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other neurological diseases,22092,112,1.09 [0.80-1.48],0.5855586063870841
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",21797,409,1.16 [0.99-1.36],0.0639308429638756
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,21636,248,1.16 [0.95-1.41],0.1554137761596222
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21448,60,1.46 [1.00-2.12],0.048124856025369
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,21519,131,1.06 [0.80-1.41],0.6862435584838255
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,21489,101,1.03 [0.74-1.43],0.8597626145909201
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17333,249,1.16 [0.95-1.42],0.149097467887374
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17679,595,1.07 [0.93-1.23],0.3249153060063121
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,21255,296,1.04 [0.86-1.27],0.6558438117016545
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22225,80,1.42 [1.03-1.95],0.0326119912226544
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2544,80,1.51 [1.07-2.13],0.0179440962777495
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",19761,80,1.39 [1.01-1.91],0.0422696039751447
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,21674,134,0.83 [0.61-1.12],0.2212658021260247
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,21612,72,0.80 [0.53-1.20],0.2800012661761398
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",21736,77,0.84 [0.57-1.23],0.3781971902841076
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,21975,97,0.98 [0.70-1.37],0.8834428334604878
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,22552,139,1.22 [0.93-1.59],0.1459642998086999
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,21447,112,1.01 [0.74-1.38],0.9459984912470272
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,13961,4490,1.11 [1.04-1.18],0.0013909590822732
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,21707,94,1.54 [1.15-2.05],0.0036758927399941
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",14780,3149,1.03 [0.96-1.10],0.3977417500205857
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertension,14822,3191,1.03 [0.96-1.10],0.4218058987798472
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,11739,108,0.99 [0.73-1.36],0.9751437492087096
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",19810,1795,1.23 [1.14-1.33],2.566465048887436e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Angina pectoris,19084,1069,1.19 [1.08-1.32],0.0004755812151225
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21279,338,1.24 [1.05-1.47],0.0103857142844266
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,21622,681,1.28 [1.14-1.44],3.8894323705365664e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22482,128,1.08 [0.82-1.42],0.6017047875394348
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",18438,423,1.39 [1.21-1.61],7.639277172758157e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,19448,1456,1.26 [1.16-1.38],9.071552807058689e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,21524,135,1.46 [1.13-1.88],0.0035554326662874
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,21737,277,1.21 [1.00-1.46],0.0473794089762557
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,21505,116,1.69 [1.31-2.17],4.234591896889658e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,21506,117,1.70 [1.33-2.18],2.865191216250041e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",11743,112,1.62 [1.25-2.10],0.0002235813618803
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16624,71,1.19 [0.82-1.74],0.3591142819809836
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Conduction disorders,16725,172,1.26 [0.99-1.59],0.05831369158599
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8831,139,0.88 [0.66-1.19],0.4143437534153992
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9365,673,1.55 [1.37-1.76],1.1581900770441222e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,16646,93,1.37 [1.00-1.86],0.046673797962242
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16672,119,1.53 [1.18-1.98],0.0012590089149773
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",21030,288,1.71 [1.47-2.01],1.7651639627264482e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",21383,196,1.16 [0.93-1.45],0.1823379376750662
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",21417,176,1.10 [0.87-1.39],0.4355819722830996
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",21528,156,1.09 [0.85-1.40],0.4974653845084721
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21045,103,1.64 [1.27-2.14],0.0001982437691261
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21110,168,1.82 [1.50-2.22],1.3895614194748551e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),20960,164,1.00 [0.77-1.29],0.9911541055937064
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,20939,143,1.12 [0.86-1.46],0.4044559209795723
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22362,137,1.16 [0.89-1.51],0.2785271969955599
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Varicose veins,21297,501,0.92 [0.79-1.08],0.3174299832676489
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypotension,20990,118,1.17 [0.87-1.56],0.3033535066279125
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,16682,2110,1.39 [1.29-1.50],5.564553384050781e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22486,76,1.16 [0.80-1.66],0.4343524637283893
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,20138,256,1.67 [1.41-1.98],3.687694204744592e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",20109,227,1.65 [1.37-1.98],7.280412663464878e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,21401,285,1.39 [1.17-1.66],0.0002001296121451
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,21392,276,1.36 [1.13-1.63],0.0008342826598154
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,21925,545,1.11 [0.97-1.28],0.1336080684342998
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,21472,92,1.09 [0.78-1.53],0.6025172960214955
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Nasal polyp,21519,139,1.17 [0.89-1.53],0.2512115893135376
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",21728,348,1.06 [0.89-1.26],0.5382025914521047
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,21513,133,0.95 [0.71-1.27],0.7208713315626676
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7184,75,1.76 [1.26-2.46],0.0009980668317334
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19611,1103,1.32 [1.20-1.46],1.046416926427071e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Early onset COPD,21018,238,1.64 [1.37-1.95],4.760255227528844e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",21068,288,1.70 [1.45-2.00],8.591019733281062e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",21068,288,1.70 [1.45-2.00],8.591019733281062e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",20992,841,1.07 [0.96-1.20],0.2333555572726501
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Asthma,14712,841,1.23 [1.09-1.39],0.0006259335543717
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14329,841,1.24 [1.10-1.39],0.0004868743397471
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14703,832,1.24 [1.10-1.40],0.0004515977179175
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22090,121,2.94 [2.43-3.56],4.303550737627779e-28
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,21056,93,3.62 [2.93-4.48],2.2759136905865484e-32
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",22184,93,3.47 [2.82-4.27],8.221129288063434e-32
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21049,86,3.41 [2.73-4.25],2.6490336751985248e-27
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural effusion,19891,142,1.60 [1.27-2.02],5.926933544469832e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,20036,287,1.78 [1.52-2.08],5.098809971876429e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,20983,128,1.73 [1.38-2.18],2.251009873406879e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14620,6307,1.02 [0.97-1.08],0.4443315217351745
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22203,323,1.12 [0.94-1.34],0.2186491689507571
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,22637,40,0.84 [0.49-1.46],0.5397617401186863
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Impacted teeth,22639,36,0.99 [0.57-1.73],0.9728425858221844
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Dental caries,21969,89,1.17 [0.84-1.63],0.3496279470446266
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,21969,89,1.19 [0.85-1.65],0.3061929951794194
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,22634,44,0.90 [0.54-1.52],0.700248525391225
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,21974,94,1.36 [1.00-1.84],0.0480432005190834
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,21707,89,1.49 [1.10-2.01],0.0104429036241812
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,22530,58,1.49 [1.03-2.17],0.0363235374583207
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15996,337,1.32 [1.11-1.56],0.0013216016317256
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18173,2514,1.11 [1.03-1.19],0.0049984987953656
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophagitis,16057,398,1.12 [0.95-1.32],0.1903463249697092
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16468,809,1.03 [0.91-1.16],0.6126579971124662
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15743,84,1.01 [0.70-1.44],0.9779744715758196
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15929,270,1.13 [0.93-1.38],0.2261368115118737
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15742,83,1.01 [0.71-1.45],0.9455500312516634
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastric ulcer,15859,200,1.38 [1.11-1.71],0.0031048073251659
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,15802,143,1.23 [0.95-1.59],0.1191718727364114
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22465,98,1.29 [0.96-1.75],0.0937856788274194
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Chronic gastritis,15802,143,1.12 [0.85-1.46],0.4238755631042439
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16623,964,1.13 [1.02-1.26],0.0229679053504793
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of appendix,22507,87,1.24 [0.88-1.75],0.2087175109182726
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,16138,479,1.00 [0.86-1.17],0.9782686183448928
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15877,218,1.23 [0.99-1.52],0.0599443986260422
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,22509,120,0.85 [0.63-1.16],0.3085238408000619
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute appendicitis,22496,76,1.31 [0.92-1.88],0.1329663864826102
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Hernia,19096,2014,0.99 [0.92-1.07],0.8006239690098765
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Inguinal hernia,17853,771,0.88 [0.77-1.00],0.043342338621145
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Umbilical hernia,17211,129,0.97 [0.72-1.29],0.8196807057730695
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ventral hernia,17189,107,1.02 [0.74-1.40],0.9051557557117452
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18179,1097,1.04 [0.94-1.16],0.4207886383989385
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,21594,744,1.05 [0.93-1.18],0.4553915646066285
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,16566,2278,1.04 [0.96-1.12],0.3551898746358722
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22294,43,1.22 [0.75-1.96],0.426422623336476
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",22577,57,1.33 [0.89-1.98],0.1645682366843756
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn disease,20907,57,1.34 [0.90-2.00],0.1536944129753177
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,20892,42,1.50 [0.96-2.33],0.0748093092162993
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",22500,141,1.02 [0.78-1.35],0.8652461874009542
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,20991,141,1.03 [0.78-1.36],0.8293696337466668
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",20981,131,1.01 [0.75-1.35],0.9534586576787264
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,21465,615,1.05 [0.92-1.20],0.4581784422013087
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,21456,606,1.06 [0.93-1.21],0.3901972111040654
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14409,121,1.02 [0.75-1.37],0.9144363135869742
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal stricture,22055,121,1.02 [0.75-1.37],0.9062536305420752
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14366,78,1.02 [0.70-1.47],0.9326982097595936
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15171,883,0.97 [0.87-1.09],0.6672950647792752
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14438,150,0.91 [0.69-1.21],0.5147142728110239
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14602,314,1.14 [0.95-1.37],0.1596217718296699
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Constipation,20574,281,1.11 [0.92-1.35],0.2751656367681425
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22164,93,0.84 [0.59-1.20],0.3311355844648525
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14393,105,0.85 [0.61-1.18],0.3281759514429897
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14338,50,1.00 [0.64-1.58],0.9931510642397646
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15244,956,1.02 [0.91-1.14],0.7569014287891065
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,14640,352,1.01 [0.85-1.21],0.897001800600458
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22148,77,0.76 [0.51-1.13],0.1704573131092203
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of liver,21771,123,1.22 [0.93-1.60],0.1479506678381532
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of liver,21719,71,1.29 [0.91-1.83],0.1537984302000911
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",21188,711,1.08 [0.95-1.22],0.2534567744998439
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholelithiasis,21060,583,1.11 [0.97-1.27],0.1434821867258807
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholecystitis,20593,116,1.07 [0.79-1.44],0.6803704883837882
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,20534,57,1.59 [1.11-2.29],0.0114317406967204
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,20546,69,0.85 [0.56-1.28],0.4289080609091493
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),22459,69,0.84 [0.55-1.27],0.4143786937218946
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,21160,329,1.01 [0.84-1.21],0.904353315940241
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,20901,70,0.94 [0.63-1.41],0.7543806998926572
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Coeliac disease,20891,60,0.94 [0.61-1.45],0.7777235881523101
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",20886,55,0.69 [0.43-1.10],0.1193692638353082
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,21040,209,1.08 [0.87-1.35],0.4833990190667375
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,GI-bleeding,21031,200,1.14 [0.91-1.42],0.2571016054560918
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,19006,1580,1.04 [0.95-1.13],0.4300590418568621
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22114,104,0.98 [0.70-1.35],0.881487527128331
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22236,432,0.88 [0.74-1.04],0.1235339391872363
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,20594,609,1.18 [1.04-1.35],0.0108887533505747
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,21617,386,1.09 [0.92-1.28],0.3190927084448358
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21302,71,0.89 [0.61-1.32],0.5703070949342437
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,21507,276,1.15 [0.95-1.39],0.1609967044784146
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22334,91,0.99 [0.70-1.40],0.9524904439139374
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22309,66,0.95 [0.63-1.43],0.7887430487243868
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22296,53,0.81 [0.50-1.30],0.3827262196051545
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22214,76,0.77 [0.51-1.16],0.2127841050505097
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22212,74,0.76 [0.50-1.15],0.1937291619218367
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,21854,50,1.02 [0.64-1.63],0.917422869776616
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22163,359,0.85 [0.71-1.02],0.0871803286034146
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20097,112,1.34 [1.01-1.77],0.0447165580703323
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20086,101,1.33 [0.98-1.80],0.0655083519039506
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20054,69,1.52 [1.08-2.14],0.0165691460219805
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20208,223,1.07 [0.86-1.34],0.5441456722651865
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20189,204,1.10 [0.88-1.38],0.4140316100064874
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,14790,4326,1.07 [1.01-1.14],0.033053157591088
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,16353,2688,1.07 [0.99-1.15],0.0696471689859712
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,20062,1279,1.04 [0.94-1.14],0.445096122828532
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,13847,182,1.24 [0.98-1.56],0.0685454137332981
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14235,570,1.16 [1.01-1.32],0.0383334201910188
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22130,176,1.24 [0.98-1.57],0.0674614160918023
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22134,160,1.26 [0.99-1.60],0.0631966812997125
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,15268,1603,1.03 [0.94-1.13],0.5207551841059881
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",17742,1603,1.02 [0.94-1.12],0.5892370624776337
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,13755,90,1.28 [0.93-1.76],0.1272298868634174
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",21887,87,1.31 [0.95-1.80],0.0983497758164318
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13944,279,1.05 [0.86-1.28],0.6103700809455932
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,13780,115,1.45 [1.11-1.90],0.0070817094083657
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14093,428,0.93 [0.78-1.10],0.3722047812005445
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22419,211,0.93 [0.73-1.17],0.522726062174321
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,14377,712,1.05 [0.93-1.20],0.4351130460933642
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14223,558,1.04 [0.90-1.20],0.5995881658162383
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,14958,1293,1.09 [0.99-1.20],0.0922303427480382
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),13757,92,0.84 [0.58-1.21],0.344941678706814
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),13957,292,1.28 [1.06-1.55],0.0106739433768449
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,13739,74,1.18 [0.81-1.72],0.3964757574063924
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),13755,90,1.03 [0.72-1.47],0.8710613026993279
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14088,423,0.95 [0.81-1.13],0.5707147481668338
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14047,382,0.98 [0.83-1.17],0.8561512561039136
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17023,271,1.23 [1.02-1.49],0.0273250552345994
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,21935,100,1.30 [0.95-1.77],0.0996000223480918
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,21905,70,1.34 [0.93-1.93],0.1105420593982004
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,18722,77,1.21 [0.85-1.72],0.3009493700951275
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,19004,359,1.16 [0.98-1.37],0.0807073791020051
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19571,926,1.16 [1.04-1.29],0.0060872434624189
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18877,232,1.28 [1.05-1.56],0.0159869257937545
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,18756,111,0.98 [0.72-1.34],0.9115102461758956
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",19331,686,1.14 [1.00-1.29],0.0433007361589252
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,18687,42,0.71 [0.41-1.23],0.2255288517555936
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,18857,212,1.19 [0.96-1.48],0.1110988208685157
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,18729,84,1.08 [0.76-1.54],0.6778286808528923
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,18731,86,1.33 [0.97-1.81],0.0769439026869047
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,18773,128,1.09 [0.82-1.44],0.5659253670363906
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,18705,60,1.16 [0.77-1.74],0.4789625525157085
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,18929,284,1.11 [0.92-1.34],0.2763323979015475
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19113,330,1.07 [0.89-1.28],0.4591234699406349
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,18863,80,1.16 [0.81-1.64],0.4152159081991693
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,18900,117,1.07 [0.79-1.45],0.6657341777573667
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,18870,87,0.86 [0.59-1.25],0.4227422457830599
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",18823,40,0.94 [0.55-1.60],0.8231015609968901
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,18945,162,0.99 [0.77-1.29],0.9680775777046584
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],18934,151,1.00 [0.77-1.31],0.979673580994181
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19076,293,1.10 [0.91-1.33],0.3184562129449653
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,18839,56,1.54 [1.07-2.21],0.0195749741409927
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,18883,100,1.04 [0.75-1.43],0.8296200639965053
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,18922,139,1.06 [0.81-1.40],0.6542445366113172
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,18831,48,0.86 [0.53-1.41],0.5589240405267042
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",19235,452,1.06 [0.91-1.24],0.443666384928479
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,18973,190,0.88 [0.69-1.13],0.3145383498131147
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19033,250,1.21 [1.00-1.47],0.0542204286148992
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,20282,238,1.26 [1.03-1.54],0.0265629074675425
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,20474,430,1.22 [1.04-1.42],0.0119059593824433
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20085,41,1.26 [0.77-2.05],0.3577180920692883
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20091,47,1.10 [0.68-1.79],0.6978359575775894
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20131,87,1.19 [0.84-1.68],0.3300213459024393
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16513,4007,1.05 [0.99-1.12],0.1160652707492178
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8748,850,0.94 [0.84-1.06],0.3310511202689558
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,18991,292,1.31 [1.09-1.56],0.0032281011105752
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,18780,81,1.01 [0.70-1.47],0.9522428371749
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19038,64,1.48 [1.06-2.08],0.0227045201138458
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,19063,89,1.47 [1.09-1.98],0.0125662967898161
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19053,79,1.56 [1.15-2.12],0.0047782854888421
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22287,248,0.93 [0.75-1.15],0.5202845148431027
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22044,89,1.32 [0.97-1.80],0.0822875455176727
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22225,186,0.98 [0.77-1.25],0.8518508078082248
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22113,74,0.75 [0.50-1.13],0.171194328016268
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19771,1175,1.00 [0.90-1.10],0.983081158732002
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Cystitis,18702,106,0.88 [0.64-1.23],0.4639960071416595
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,18690,94,1.04 [0.74-1.46],0.8169217186675223
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18954,358,1.01 [0.84-1.20],0.9396625163109508
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,18732,136,1.01 [0.76-1.34],0.9317160033096328
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,19313,717,0.99 [0.87-1.13],0.8904509845453847
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8382,484,0.97 [0.83-1.13],0.7014980232529509
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),7966,68,0.72 [0.46-1.11],0.1317614136263036
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,7959,61,0.67 [0.43-1.05],0.0792190417734644
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",7969,71,0.82 [0.55-1.22],0.3278184815530206
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,7992,94,0.95 [0.68-1.33],0.7660341157298096
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8010,112,1.11 [0.82-1.49],0.5086583111237751
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11692,227,0.92 [0.73-1.16],0.4820813301530391
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11541,76,0.64 [0.41-0.99],0.0463050848275799
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,11544,79,1.17 [0.82-1.68],0.3926627028372168
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11523,58,1.02 [0.66-1.59],0.9167152345872092
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11670,161,0.92 [0.69-1.22],0.5548936562954383
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,11558,49,0.86 [0.51-1.45],0.5736199844618037
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11562,53,0.73 [0.44-1.21],0.225461001990962
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10809,1775,0.98 [0.90-1.08],0.7132376248855861
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9097,63,0.84 [0.53-1.33],0.4505335580636468
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9085,51,0.80 [0.48-1.34],0.4032835690940871
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9511,477,0.94 [0.80-1.11],0.4511689309309437
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9139,105,0.84 [0.60-1.20],0.3442697066736194
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9504,470,1.02 [0.87-1.20],0.8016584981487004
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9182,148,1.17 [0.90-1.54],0.2417736387669774
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9253,219,1.15 [0.92-1.43],0.2298295939346701
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9051,17,1.07 [0.47-2.41],0.8780802129895794
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9080,46,0.77 [0.45-1.32],0.3434357862137027
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",11815,62,0.68 [0.43-1.09],0.1060295132157144
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,11817,57,0.71 [0.43-1.15],0.1602768171223741
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,11823,28,0.75 [0.39-1.44],0.3830974368855075
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",11821,32,0.76 [0.41-1.41],0.3851020933473764
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9106,72,1.49 [1.07-2.07],0.0180802457365297
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9085,51,1.11 [0.70-1.78],0.6548294750112025
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9099,65,0.81 [0.52-1.27],0.3606679932418978
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,11822,89,1.06 [0.74-1.53],0.7482648840043267
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9226,192,1.02 [0.79-1.32],0.8621625040691607
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9121,87,0.99 [0.68-1.45],0.963981803665284
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",11824,39,0.92 [0.52-1.63],0.7686149408817097
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9145,111,0.91 [0.65-1.28],0.5823082190478942
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9083,49,0.86 [0.52-1.43],0.5704485926270395
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9655,621,0.95 [0.82-1.09],0.444345608213925
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22094,85,1.09 [0.77-1.54],0.622881455348627
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19262,651,1.18 [1.04-1.34],0.0106175110103866
